Covered recipient · General Payments record
SAM QIANCHENG SUN
Allopathic & Osteopathic Physicians Radiology Radiation Oncology
General Payments · PY2019–2024
$11,221.99
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,574.05 | 54 |
| Consulting Fee | $1,050.00 | 2 |
| Travel and Lodging | $75.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $1,306.15 | 9 |
| PFIZER INC. | $266.10 | 11 |
| Regeneron Healthcare Solutions, Inc. | $160.05 | 2 |
| Janssen Biotech, Inc. | $153.48 | 6 |
| Merck Sharp & Dohme Corporation | $139.11 | 3 |
| JAZZ PHARMACEUTICALS INC. | $131.46 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $65.82 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $41.71 | 2 |
| TerSera Therapeutics LLC | $37.89 | 1 |
| ABBVIE INC. | $33.23 | 2 |
| Daiichi Sankyo Inc. | $29.74 | 1 |
| Genmab U.S., Inc. | $29.20 | 1 |
| Adaptive Biotechnologies Corporation | $27.92 | 1 |
| Geron Corporation | $27.65 | 1 |
| Astellas Pharma US Inc | $27.08 | 1 |
| Lilly USA, LLC | $26.85 | 1 |
| ADC Therapeutics America, Inc. | $24.51 | 1 |
| Ipsen Biopharmaceuticals, Inc | $23.78 | 1 |
| Incyte Corporation | $22.01 | 1 |
| EISAI INC. | $20.81 | 1 |
| Exelixis Inc. | $19.91 | 1 |
| Genentech USA, Inc. | $18.42 | 1 |
| Novocure Inc. | $18.32 | 1 |
| Pharmacosmos Therapeutics Inc. | $17.58 | 1 |
| Mirati Therapeutics, Inc. | $16.88 | 1 |
| SOBI, INC | $13.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (57)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.